Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin

The Journal of Antimicrobial Chemotherapy
Mark H Wilcox, R Howe

Abstract

One hundred patients, known to have been excreting Clostridium difficile cytotoxin in faeces, were reviewed retrospectively to determine the response time for treatment with oral metronidazole and vancomycin, and the effect of the additional administration of anti-motility agents. Records were available for 78 patients of whom 58 had received treatment with either metronidazole or vancomycin. Response and relapse rates were similar for the two treatment regimens. However, the mean duration of symptoms was significantly shorter in evaluable patients treated with vancomycin (3.0 days, n = 22) compared with those given metronidazole (4.6 days, n = 28) (Mann-Whitney-U, P < 0.01). No difference in the duration of symptoms, irrespective of antibiotic therapy, was associated with use of anti-motility agents. The increased cost of vancomycin compared with metronidazole for the treatment of C. difficile infection may be justifiable by reductions in the length of stay in hospital or in the need for nursing in isolation facilities, consequent upon a shorter symptomatic response time. Administration of anti-motility agents did not appear to impair response in patients with mild to moderate C. difficile infection.

Citations

May 20, 2008·Inflammatory Bowel Diseases·Mazen IssaDavid G Binion
May 5, 2005·Irish Journal of Medical Science·R M McLoughlin, H J O'Connor
May 11, 2010·Techniques in Coloproctology·B FarisN Haboubi
Oct 19, 2002·International Journal of Antimicrobial Agents·Wafaa Y JamalV O Rotimi
May 24, 2003·Best Practice & Research. Clinical Gastroenterology·Mark H Wilcox
Jun 10, 2000·Journal of Clinical Pharmacy and Therapeutics·F A Al-EidanM P Kearney
Oct 31, 2008·The New England Journal of Medicine·Ciarán P Kelly, J Thomas LaMont
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John G Bartlett
Feb 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dale N GerdingRobert C Owens
May 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Wafa N Al-NassirCurtis J Donskey
Jun 30, 2010·Surgical Infections·Andrea D OlivasJohn C Alverdy
Jul 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anilrudh A Venugopal, Stuart Johnson
Jul 9, 2008·The Journal of Antimicrobial Chemotherapy·Rachael O'ConnorMark H Wilcox
Aug 12, 2008·The Journal of Antimicrobial Chemotherapy·Simon D BainesMark H Wilcox
Dec 30, 2008·The Journal of Antimicrobial Chemotherapy·Simon D BainesMark H Wilcox
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Jane FreemanMark H Wilcox
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Simon D BainesMark H Wilcox
Jan 16, 2004·Gut·A C Casburn-Jones, M J G Farthing
Jul 31, 1998·Postgraduate Medical Journal·Y K Viswanath, C D Griffiths
May 7, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stuart JohnsonUNKNOWN Polymer Alternative for CDI Treatment (PACT) investigators
May 7, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark H Wilcox
Oct 15, 2014·Surgical Infections·Kathleen B To, Lena M Napolitano
Apr 18, 1998·Medizinische Klinik·W FischbachH Zirngibl
May 9, 2015·Critical Reviews in Microbiology·Melina KachrimanidouNikolaos Malisiovas
May 22, 2009·Gastroenterology·Daniel A Leffler, J Thomas Lamont
Jun 28, 2007·Pharmacotherapy·Nicole L McMaster-Baxter, Daniel M Musher
Sep 1, 1996·The Journal of Hospital Infection·M H WilcoxC Redpath
Aug 4, 2015·Drugs & Aging·Masako MizusawaSherwood Gorbach
May 5, 2012·Gut Microbes·Emma L BestMark H Wilcox
Jan 13, 2015·Infectious Disease Clinics of North America·Melinda M Soriano, Stuart Johnson
Oct 15, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S B DebastUNKNOWN European Society of Clinical Microbiology and Infectious Diseases
Jun 16, 2007·Journal of the American Medical Directors Association·Alex T Makris, Steven Gelone
Nov 20, 2016·Pharmacotherapy·Teena ChopraSherwood L Gorbach
Feb 26, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Gayle L BykerAnurag N Malani
Jun 12, 2013·Journal of Intensive Care Medicine·J T Higa, C P Kelly
Feb 21, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Clifford McDonaldMark H Wilcox
Jun 4, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Clifford McDonaldDale N Gerding
Nov 11, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Rosa F YehUNKNOWN Houston Infectious Disease Network
Apr 5, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jennifer Halsey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Daniel M MusherRichard J Hamill
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
C WenischW Graninger
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Wafa N Al-NassirCurtis J Donskey
© 2021 Meta ULC. All rights reserved